Xiaopo Tang

Dr. Xiaopo Tang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QJQuan Jiang
Quan Jiang
XTXiaopo Tang
Xiaopo Tang
XCXian-Chun Chen
Xian-Chun Chen
HXHong Xiao
Hong Xiao
PLPing Liu
Ping Liu
JJJuan Jiao
Juan Jiao
Chinese external therapy (CET) is a topical application with mainly Chinese herb medicine therapy with thousands of years of historical implications and is a clinical routine that is commonly used for relieving joint-related symptoms in patients with arthritis in Chinese hospitals. However, there is a paucity of modern medical evidence to support its effectiveness and safety. Thus, we propose to implement a randomized, double-blinded, placebo-controlled clinical trial in patients with rheumatoid arthritis (RA) using, as the experimental intervention, topical application of a hospital-compounded gel preparation of Tripterygium wilfordii Hook F (TwHF). This study will be an 8-week double-blinded, randomized, placebo-controlled clinical trial conducted at Guang’anmen Hospital in Beijing, China, and 168 patients with moderately active RA will be randomly assigned with a 1:1 ratio to apply a topical gel preparation containing TwHF or placebo. The primary outcome variable will be the proportion of subjects, by study group, to achieve a 20% improvement in the American College of Rheumatology criteria (ACR20) by week 8. Secondary outcome measures to be assessed at weeks 4 or 8 will include: measurement of ACR20 response rate at week 4, ACR50 response rate, the changes in DAS28 score, and joint synovitis classification assessment monitored by musculoskeletal ultrasound. Safety evaluations conducted at weeks 4, 8 and 12 will be based on spontaneous complaints by the study subjects, but special emphasis will be focused on cutaneous allergy and alterations of menstruation in premenopausal female participants. Statistical analyses will be performed using the intention to treat analysis data set. This proposed clinical trail is designed to evaluate the efficacy and safety of CET based on a single topically-applied agent in a relatively large patient population with RA. This study protocol gives a detailed description of the usage and dosage of the topical compound TwHF gel and the methodology of this study. In addition, it is hoped that the outcomes of this study will be viewed as supporting the generalizability of CET in the setting of inflammatory rheumatic diseases. The results of this study are expected to have important public health implications for Asian RA patients that currently utilize CET as a complimentary treatment. Clinical trial gov Identifier: NCT02818361 . Registrated on Jun. 15, 2016.

5 February 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QPQiuwei Peng
Qiuwei Peng
JWJian Wang
Jian Wang
KLKesong Li
Kesong Li
CXCongming Xia
Congming Xia
CYChuanhui Yao
Chuanhui Yao
QJQuan Jiang
Quan Jiang
Background: Plant active substances are extensively utilized in treating rheumatoid arthritis (RA). Despite numerous experimental and clinical studies on plant active substances their efficacy remains largely unsubstantiated. The widespread use of these extracts as therapeutic measures for RA is problematic due to the lack of compelling evidence.Objective: Our research aims to assess the impact of plant active substances on RA by conducting a network meta-analysis.Methods: We systematically searched four electronic databases—PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science—from their inception to August 2024. The main focus was on assessing primary outcomes, including the Visual Analogue Scale (VAS), inflammatory markers, Swollen Joint Count (SJC), Tender Joint Count (TJC), and Disease Activity Score on 28 joints (DAS28). We performed data analysis using StataMP 15.1 software and ranked the therapeutic effects based on the Surface Under the Cumulative Ranking Curve (SUCRA) probability values.Results: Based on screening procedures, 18 eligible studies were incorporated into the analysis. These studies encompassed a total of 1,674 RA patients and investigated 10 different plant active substance therapies. Specifically, 10 studies included VAS indicators, 17 studies included inflammatory marker indicators, 14 studies included DAS28 indicators, 13 studies included SJC indicators, and 13 studies included TJC indicators. Based on SUCRA values, quercetin appeared to be the most effective treatment for decreasing serum VAS levels (67.3%). Furthermore, curcumin emerged as the most promising option for reducing inflammatory marker levels (72.3%), SJC (75.6%), and TJC (76.2%). Lastly, with respect to DAS28, resveratrol emerged as the optimal choice (74.3%).Conclusion: According to the network meta-analysis (NMA), curcumin exhibited superior efficacy compared to placebo in decreasing SJC and TJC. Additionally, curcumin demonstrated greater effectiveness in reducing inflammatory markers. Quercetin was more effective in reducing VAS, and resveratrol was more effective in reducing DAS28. Patients with RA may benefit from these findings. Insightful information from this study is helpful for RA patients to consider using plant active substance therapies. For their efficacy and safety to be confirmed, more proof is needed.

30 July 2023 in Oral Diseases
Verified
Journal Article
Open access
RLRuihua Liu
Ruihua Liu
YZYi Zhang
Yi Zhang
KLKesong Li
Kesong Li
HXHaodong Xu
Haodong Xu
ZCZengyu Cheng
Zengyu Cheng
QJQuan Jiang
Quan Jiang
Aim: The aim of the study was to observe the effect of acupuncture on regulating interleukin (IL)‐17, tumor necrosis factor (TNF)‐ɑ, and aquaporins (AQPs) in Sjögren's syndrome (SS) on patients and on non‐obese diabetic (NOD) models.Methods: Levels of anti‐AQP 1, 5, 8, and 9 antibodies, IL‐17, and TNF‐ɑ in the serum of SS patients were compared prior and following 20 acupuncture treatment visits during 8 weeks. While in murine model, five groups were divided to receive interventions for 4 weeks, including control, model, acupuncture, isoflurane, and hydroxychloroquine. The submaxillofacial gland index, histology, immunohistochemistry of AQP1, 5, salivary flow, together with IL‐17, and TNF‐ɑ expression in peripheral blood were compared among the groups.Results: Acupuncture reduced IL‐17, TNF‐ɑ, and immunoglobin A levels, and numeric analog scale of dryness in 14 patients with SS (p < 0.05). The salivary flow was increased, and the water intake decreased in NOD mice receiving acupuncture treatments. IL‐17 and TNF‐ɑ levels in peripheral serum were down‐regulated (p < 0.05) and AQP1, 5 expression in the submandibular glands up‐regulated in mice.Conclusion: The effect on relieving xerostomia with acupuncture may be achieved by up‐regulating the expression of AQP1. AQP5, down‐regulating levels of IL‐17 and TNF‐ɑ, and a decrease in inflammation of glands.

26 June 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
FPFengtao Pang
Fengtao Pang
QJQuan Jiang
Quan Jiang
XTXiaopo Tang
Xiaopo Tang
KLKesong Li
Kesong Li
Objective: To explore the mechanisms of Lushi Runzao decoction (LSRZT) in Treating Sjögren’s Syndrome (SS) through gut flora, short-chain fatty acid (SCFAs) and metabolomics.Methods: Non Obese Diabetes (NOD) /LtJ mice were used as the model group, LSRZT and hydroxychloroquine (HCQ) were administered to the treatment group. Fecal samples were collected 4 weeks after the intervention. The microbiota, SCFAs and metabolites were analyzed using 16S ribosomal Ribonucleic Acid, Gas chromatography mass spectrometry analysis and Ultra High Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.Results: LSRZT had obvious anti-inflammatory effect and can effectively improve the functional injury of submandibular gland; It improves the imbalance of gut microbiota and the related metabolic levels of SCFAs and bile acids, and regulates the levels of inflammatory factors and the contents of bile acids and caproic acid by regulating the abundance of Erysipelatoclostridiaceae, Gammaproteobacteria and Ruminococcaceae.Conclusion: LSRZT can reduce the level of inflammation and improve the imbalance of gut microbiota and metabolism. It provides a scientific basis for the clinical treatment of SS by LSRZT.

1 July 2025 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
JHJiale He
Jiale He
ZLZixia Liu
Zixia Liu
XTXiaopo Tang
Xiaopo Tang
The accurate prediction of epitopes associated with Systemic Lupus Erythematosus (SLE) plays a vital role in advancing our understanding of autoimmune pathogenesis and in designing effective immunotherapeutics. Traditional bioinformatics methods often struggle to capture the intricate sequence patterns and high-dimensional signals characteristic of epitope data. Deep learning presents a compelling alternative, with its ability to perform automatic feature learning and model complex dependencies inherent in biological sequences. This study proposes a hybrid deep learning architecture that synergistically integrates handcrafted biochemical features with data-driven deep sequence modeling to improve the identification of SLE-associated epitopes. The framework comprises six interconnected components: (1) handcrafted feature extraction encoding biochemical and physicochemical attributes; (2) an embedding layer for dense sequence representation; (3) a Convolutional Neural Network (CNN) branch that captures local patterns from handcrafted features; (4) a Long Short-Term Memory branch for learning temporal dependencies in sequence data; (5) a scaled dot-product attention-based fusion module that integrates complementary information from both branches; and (6) a Multi-Layer Perceptron for final classification. Model evaluation employed metrics such as Accuracy, Precision, Recall, F1-score, and the area under the receiver operating characteristic curve (ROCAUC). The hybrid model outperformed both baseline machine learning algorithms and ablated versions of itself. It achieved a ROCAUC of 0.9506 and an F1-score of 0.8333 on the SLE epitope prediction task. Notably, ablation studies revealed that the CNN component had the most substantial influence on performance, while the custom fusion mechanism yielded better integration of features than conventional strategies. These findings underscore the model’s robustness and capacity to generalize across complex epitope prediction tasks. This work presents an interpretable, biologically informed deep learning approach for predicting SLE-associated epitopes. By merging domain-specific handcrafted features with dynamic deep learning representations, the model not only enhances predictive accuracy but also provides meaningful biological insights. The framework holds promise for broader applications in immunoinformatics and autoimmune disease research.

30 July 2024 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
RLRuihua Liu
Ruihua Liu
ZGZilin Guo
Zilin Guo
HXHaodong Xu
Haodong Xu
JHJing He
Jing He
BWBei Wang
Bei Wang
新周新尧 周
新尧 周
Background: This study explored similarities and differences among Chinese patients and rheumatologists in their attitudes towards and perceptions of traditional Chinese medicine (TCM) for Sjögren’s syndrome (SS), including analyzing factors that influenced their decision making. Methods: An anonymous questionnaire was used to conduct a multicenter survey among patients with SS at three tertiary care medical centers in Beijing and among rheumatology clinicians at several hospitals across China. Results were analyzed using descriptive statistics. Results: There were 942 valid questionnaires from patients from 31 provinces and cities in China, with a male-to-female ratio of approximately 1:14, a mean age of 48.81 years, and a median disease duration of 7 (4, 10) years. There were 320 valid questionnaires from rheumatologists, covering 30 provinces and cities in China, with a male-to-female ratio of approximately 0.87:1, a mean age of 48 years, and a median work duration of 10.5 (6, 15) years. The rheumatologists treated a median of 15 (11, 50) SS cases per month, and the median proportion of SS to all rheumatic diseases was 6.66% (6–10%). Many patients believed TCM could cure the root of the disease, and the most expected TCM therapies were TCM patent prescriptions and medicinal teas. Conversely, rheumatologists placed high value on the efficacy of TCM, and most commonly prescribed Chinese herbal decoctions. Most doctor-patient groups were positive about TCM treatment, citing the low side effects as the major advantage. Regression analysis showed that for patients over 40 years old with a course of disease > 4 years, the probability of using TCM has increased by 1–6 times; the probability of recommending TCM in clinical work of doctors who have worked for more than 15 years, TCM and integrated traditional Chinese and western medicine has increased 1–2 times. Conclusions: TCM has become widely accepted and earned attention from doctor-patient groups, especially among older patients and experienced rheumatologists. However, negative prejudices and absence of accurate information about TCM treatments and SS itself require improvement. The contradiction between TCM dosage form and efficacy is a major problem, and patient demand for convenient and efficient TCM patent preparations suggests future work should focus on developing TCM patent preparations with clear compositions and mechanisms.